Wenshan Lin
Overview
Explore the profile of Wenshan Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin S, Lin W, Zhong Z, Zhong H, Zhou T, Weng W
Curr Mol Med
. 2023 Nov;
24(12):1540-1549.
PMID: 37936436
Objective: To explore a new approach for the treatment of renal interstitial fibrosis (RIF), we detected the expression of matrix metalloproteinase-9 (MMP9) and vascular endothelial growth factor (VEGF). Methods: Twenty-four...
2.
Zhong Z, Li H, Zhong H, Lin W, Lin S, Zhou T
Ren Fail
. 2021 Apr;
43(1):658-663.
PMID: 33820492
All-trans retinoic acid (ATRA) is one of essentially active metabolite of vitamin A, and plays an important role in diverse physiological processes, such as cellular growth and function. Renal interstitial...
3.
Lin S, Lin W, Liao C, Zhou T
Stem Cells Int
. 2021 Jan;
2020:8819757.
PMID: 33424979
Background: Renal damage caused by drug toxicity is becoming increasingly common in the clinic. Preventing and treating kidney damage caused by drug toxicity are essential to maintain patient health and...
4.
Lin W, Li H, Yang Q, Chen G, Lin S, Liao C, et al.
Stem Cell Res Ther
. 2021 Jan;
12(1):43.
PMID: 33413678
Background: Mesenchymal stem cell (MSC) therapy shows great promise for diabetic kidney disease (DKD) patients. Research has been carried out on this topic in recent years. The main goals of...
5.
Zhou T, Lin W, Lin S, Zhong Z, Luo Y, Lin Z, et al.
Biomed Res Int
. 2020 Sep;
2020:1587915.
PMID: 32884936
Nuclear receptor coactivators (NCOAs), consisting of coactivators and corepressors, dramatically enhance the transcriptional activity of nuclear receptors. Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that plays a major role under...
6.
Zhou T, Liao C, Lin S, Lin W, Zhong H, Huang S
Stem Cells Int
. 2020 Aug;
2020:1873921.
PMID: 32831852
Mesenchymal stem cells (MSCs), discovered and isolated from the bone marrow in the 1960s and with self-renewal capacity and multilineage differentiation potential, have valuable immunomodulatory abilities. Acute kidney injury (AKI)...
7.
Zhong H, Lin W, Zhou T
J Pharm Pharm Sci
. 2020 Aug;
23:278-288.
PMID: 32762831
Anemia is a common complication of chronic kidney disease (CKD), and its prevalence has shown a tendency to increase in many countries. Anemia is associated with incident heart failure and...
8.
Zhou T, Li H, Liao C, Lin W, Lin S
Stem Cells Int
. 2020 Apr;
2020:6518508.
PMID: 32322279
Systemic lupus erythematosus (SLE) is a polymorphic, multisystemic autoimmune disease that causes multiorgan damage in which cellular communication occurs through the involvement of autoantibodies directed against autoantigen production. Mesenchymal stem...
9.
Zhou T, Liao C, Li H, Lin W, Lin S, Zhong H
Stem Cell Res Ther
. 2020 Feb;
11(1):48.
PMID: 32019582
Background: Lupus nephritis is usually manifested by proteinuria, active urinary sediment, hypertension, and renal failure and is a serious complication with more than 50% occurrence in systemic lupus erythematosus patients....
10.
Zhou T, Zhang X, Lin W, Lin S
J Pharm Pharm Sci
. 2019 Oct;
22(1):365-375.
PMID: 31580800
Introduction: We evaluated the effectiveness and safety of various multitarget therapies for inducing remission in lupus nephritis patients. Methods: Randomized controlled trials (RCT) were identified and extracted from the Embase,...